S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

FWBI First Wave BioPharma Inc

2.64

0.04 (1.54%)

After Hours

Last Updated: 08:00:01

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
tm2315784-1_ars.pdf

First Wave BioPharma (NASDAQ:FWBI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more First Wave BioPharma Charts.

First Wave BioPharma (NASDAQ:FWBI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more First Wave BioPharma Charts.

First Wave Biopharma, Inc. News

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
Wednesday 24 April 2024 (2 weeks ago) • GlobeNewswire Inc.

First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
Wednesday 17 April 2024 (3 weeks ago) • GlobeNewswire Inc.

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
Tuesday 13 February 2024 (3 months ago) • GlobeNewswire Inc.

First Wave BioPharma to Present at the DealFlow MicroCap Conference
Tuesday 23 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 19 January 2024 (4 months ago) • Edgar (US Regulatory)

More First Wave Biopharma, Inc. News Articles

Westpac Banking

Commonwealth Bank Of Aus...

Woodside Petroleum

National Australia Bank

Invesco QQQ Trust Series 1

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions